SAB Biotherapeutics Inc reports results for the quarter ended in January - Earnings Summary

SAB Biotherapeutics

20/05/2024 23:36

* SAB Biotherapeutics Inc  SABS.OQ  reported a quarterly
adjusted
loss of 60 cents​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of $-1.50.  The mean expectation of two analysts
for the quarter was for a loss of 96 cents per share. Wall
Street expected results to range from -98 cents to -94 cents per
share.
    * Revenue rose 62.5% to $944.00 thousand from a year ago;
analysts
expected zero. 
    * SAB Biotherapeutics Inc's reported EPS for the quarter was
a
loss of 54 cents​.
    * The company reported a quarterly loss of $5.12 million.
    * SAB Biotherapeutics Inc shares had fallen by 20.0% this
quarter and lost 47.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 108.7% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for SAB
Biotherapeutics Inc is $15.50 
This summary was machine generated from LSEG data May 20 at
10:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.96          -0.60          Beat
 Dec. 31 2023      -0.62          -3.38          Missed
 Sep. 30 2023      -1.17          -1.00          Beat
 Jun. 30 2023      -1.45          -1.40          Beat